Lucira Health’s Covid-19 test kit detects double mutant variants
The LUCIRA Covid-19 All-In-One Test Kit is an FDA-authorised, prescription, molecular diagnostic test that delivers results within 30…
Sanofi acquires mRNA-based technology firm Tidal Therapeutics
12 Apr 21With the acquisition, Sanofi is expected to benefit from a new technology platform that expands its research capabilities…
Hologic to acquire molecular diagnostics firm Mobidiag for $795m
09 Apr 21The acquisition of Mobidiag will strengthen Hologic’s international and diagnostics businesses
Biogen gains rights to tocilizumab biosimilar BAT1806 from Bio-Thera
09 Apr 21Biogen will make an upfront payment of $30m to Bio-Thera Solutions, based on the success of Phase 3…
Gilead gets FDA approval for Trodelvy to treat metastatic TNBC
08 Apr 21Trodelvy is an antibody and topoisomerase inhibitor conjugate that targets Trop-2 receptor, a protein often expressed in epithelial…
Roche rolls out Elecsys Anti-p53 immunoassay for early cancer diagnosis
08 Apr 21Elecsys Anti-p53 is a high precision immunoassay that leverages well-established electrochemiluminescence immunoassay (ECLIA) technology
Abbott’s XIENCE stent granted CE Mark for shorter DAPT in HBR patients
07 Apr 21EC approval is supported by the results from XIENCE 28 and XIENCE 90 clinical trials
Catalent, Moderna extend partnership for Covid-19 vaccine production
07 Apr 21Catalent will dedicate a new high-speed filling line at the Bloomington site to manufacture Moderna’s Covid-19 vaccine through…
Orthofix gets FDA approval for CONSTRUX Mini Ti cervical spacer system
06 Apr 21The CONSTRUX Mini Ti System is designed with nanoscale surface features and is said to be the first…
IceCure gets FDA Breakthrough Device Designation for ProSense cryoablation system
06 Apr 21The US regulator indicated ProSense for the treatment of T1 invasive breast cancer and breast cancer for patients…